KV Faces Class Action Over Recalled Generic Toprol

By Jocelyn Allison · April 16, 2009, 12:00 AM EDT

KV Pharmaceutical Co. and two of its subsidiaries have been hit with a proposed class action over their manufacturing practices for a hypertension medication that was among several KV drugs recalled...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Recent Articles By Jocelyn

February 22, 2019
Tracing Puerto Rico's Journey Through Bankruptcy
November 09, 2016
After Trump's Triumph, What's Next?
January 21, 2011
United, Merck Hit With Navy Communications IP Suits
January 19, 2011
FDA Unveils Changes To Medical Device Review Process
January 19, 2011
8th Circ. Revives Class Action Over KV Recalls
January 18, 2011
Weil Advises Advent In $1.5B Buy Of Priory From RBS
January 13, 2011
Ex-Home Diagnostics CEO Charged With Insider Trading
January 04, 2011
FDA Tackles Food Safety As Funding Remains Uncertain
December 16, 2010
Elan, Eisai To Pay $214M Over Zonegran Marketing
December 15, 2010
FDA Warns Of Hidden Ingredients In Supplements